While ERA modulates ECM components in breast cancer [21] and its expression is used to guide breast cancer treatment [22], there is no established association between ERA and ECM steady-state transcript levels in E2 treated-dermal tissue. This evidence concerns the gene ESR1 and breast carcinoma.